Development of RP-HPLC method for simultaneous estimation of atorvastatin calcium and clopidogrel bisulphate in a pharmaceutical capsule dosage form

Research Journal of Pharmacy and Technology

Volumn 5, Issue 5, 2012, Pages 641-644

  Dangre, S C ^a   Shah, S K ^b   Suruse, Pravin B ^a   Bhusari, K P ^a  

^a Nagar Yuwak Shikshan Sanstha   (India)

^b Maharashtra Industrial Development Corporation India   (India)

Author keywords

Atorvastatin calcium; Clopidogrel bisulphate; Method development; Pharmaceutical formulation; RP HPLC; Validation

Indexed keywords

ATORFIT; ATORVASTATIN; ATORVASTATIN PLUS CLOPIDOGREL; CLOPIDOGREL; UNCLASSIFIED DRUG;

ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG CAPSULE; DRUG DETERMINATION; DRUG MONITORING; DRUG STRUCTURE; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

EID: 84863665604     PISSN: 0974360X     EISSN: 09743618     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. P. L. Andrew and D. McTavish. Atorvastatin: a review of its pharmacology and therapeutic potential in the management of hyperlipidemias, Journal of Food and Drug Analysis 53: 828-847 (2007)
2. W. W. Bullen, R. A Miller and R. N. Haye. Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and parahydroxy atorvastatin in human, dog, and rat plasma J. Am. Soc. Mass Spectrom 10: 55-66 (1999)
3. M. Jemal, Z. Ouyang, B. C. Chen and D. Teitz. Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometry, Rapid Commun. Mass Spectrom 13: 1003-1015 (1999)
4. M. Hermann, H Christensen, and J. L Reubsaet. Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS, Anal. Bioanal. Chem 382: 1242-1249 (2005)
5. S. Erturk, E. A. Sevinc, L. Ersoy, and S. Ficicioglu. An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets, J. Pharm. Biomed. Anal 33: 1017-1023 (2003)
6. A. Zarghi, A. Shafaati, S. M. Foroutan and A. Khoddam. A simple and rapid HPLC method for the determination of atorvastatin in human plasma with UV detection and its application to pharmacokinetic studies, Arzneimittelforschung 55: 451-454 (2005)
7. Bahrami G, Mohammadi B, Mirzaeei S and Kiani A. Determination of atorvastatin in human serum by reversed-phase high-performance liquid chromatography with UV detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;82: 41-45
8. B. Jarvis and K. Simpson. Clopidogrel: a review of its use in the prevention of atherothrom-bosis, Drugs 60: 347-377 (2000)
9. P. A. Gurbel, C. M. O'Connor, C. C. Cummings and V. L. Serebruany. Clopidogrel: the future choice for preventing platelet activation during coronary stenting, Pharmacol. Res. 40: 107-111 (1999)
10. K Anandakumar, T Ayyappan, V Raghu Raman, T Vetrichelvan, A.S.K Sankar, D Nagavalli. RP-HPLC analysis of aspirin and clopidogrel bisulphate in combination. Indian J Pharm Sci 2007;69:597-599
11. N. K. Patel, G. Subbaiah, H. Shah, M. Kundlik, P. S. Shrivastav. Rapid LC-ESI-MS-MS method for the simultaneous determination of clopidogrel and its carboxylic acid metabolite in human plasma. J Chromatogr Sci 2008 Nov-Dec;46(10):867-875
12. X. Delavenne, T. Basset, P. Zufferey, N. Malouk, S. Laporte, P. Mismetti. X. Delavenne, T. Basset, P. Zufferey, N. Malouk, S. Laporte, P. Mismetti. J Sep Sci 2010 Jul;33(13):1968-1972
13. Validation of Analytical Procedures: Methodology (Q2B), ICH Harmonized Tripartite Guidelines
14. ICH, Text on validation of analytical procedures. Q2A